» Articles » PMID: 39586277

Treatment with Long-Acting Somatostatin Analogues in Patients with Acromegaly: When and How

Overview
Journal Front Horm Res
Date 2024 Nov 25
PMID 39586277
Authors
Affiliations
Soon will be listed here.
Abstract

Somatostatin and its analogs have been for years a mainstay treatment for a variety of hypersecretory conditions and neoplasms of the endocrine system. This chapter summarizes their pharmacological properties, their indication in the context of acromegaly, and the best way to handle this class of drugs for the treatment of the patient with acromegaly.